| MSCOX | VSGIX | MSCOX / VSGIX | |
| Total Expense Ratio | 2.10 | 0.05 | 4,200% |
| Annual Report Gross Expense Ratio | 2.29 | 0.05 | 4,580% |
| Fund Existence | 9 years | 26 years | - |
| Gain YTD | 11.875 | 18.879 | 63% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 239M | 43.9B | 1% |
| Annual Yield % from dividends | 0.00 | 0.45 | - |
| Returns for 1 year | 5.92 | 26.41 | 22% |
| Returns for 3 years | 66.20 | 62.78 | 105% |
| Returns for 5 years | -47.74 | 29.94 | -159% |
| Returns for 10 years | N/A | 176.32 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AFRU | 10.99 | 0.45 | +4.26% |
| T-REX 2X Long AFRM Daily Target ETF | |||
| LFSC | 47.80 | 0.35 | +0.75% |
| F/m Emerald Life Sciences Innovation ETF | |||
| SPXX | 19.08 | 0.09 | +0.47% |
| Nuveen S&P 500 Dynamic Overwrite Fund | |||
| IBND | 31.37 | 0.01 | +0.03% |
| State Street® SPDR® Blmbg Intl CorpBdETF | |||
| CPSF | 26.50 | N/A | N/A |
| Calamos S&P 500 Str Alt Prt ETF-Feb | |||